Cargando…
Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells
Glioblastomas are highly malignant brain tumors that derive from brain-tumor-initiating cells (BTICs) and can be subdivided into several molecular subtypes. Metformin is an antidiabetic drug currently under investigation as a potential antineoplastic agent. The effects of metformin on glucose metabo...
Autores principales: | Seliger, Corinna, Rauer, Lisa, Wüster, Anne-Louise, Moeckel, Sylvia, Leidgens, Verena, Jachnik, Birgit, Ammer, Laura-Marie, Heckscher, Simon, Dettmer, Katja, Riemenschneider, Markus J., Oefner, Peter J., Proescholdt, Martin, Vollmann-Zwerenz, Arabel, Hau, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962848/ https://www.ncbi.nlm.nih.gov/pubmed/36834608 http://dx.doi.org/10.3390/ijms24043199 |
Ejemplares similares
-
Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin
por: Seliger, Corinna, et al.
Publicado: (2022) -
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
por: Leidgens, Verena, et al.
Publicado: (2016) -
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
por: Gerthofer, Valeria, et al.
Publicado: (2018) -
ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)
por: Moeckel, Sylvia, et al.
Publicado: (2019) -
Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms
por: Leidgens, Verena, et al.
Publicado: (2015)